Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 2:33 pm Sale |
2021-12-31 | 13G | Metacrine, Inc. MTCR |
venBio Global Strategic Fund L.P. | 0 0.000% |
-3,059,123 (Position Closed) |
Filing History |
| 2021-02-16 4:53 pm Purchase |
2020-12-31 | 13G | Metacrine, Inc. MTCR |
venBio Global Strategic Fund L.P. | 3,059,123 11.800% |
3,059,123 (New Position) |
Filing History |
| 2020-07-09 5:28 pm Sale |
2020-07-07 | 13D | Precision BioSciences, Inc. DTIL |
venBio Global Strategic Fund L.P. | 84,745 4.900% |
-17,370 (-17.01%) |
Filing History |
| 2020-07-08 3:54 pm Purchase |
2020-07-06 | 13D | Akero Therapeutics, Inc. AKRO |
venBio Global Strategic Fund L.P. | 3,033,552 10.600% |
3,033,552 (New Position) |
Filing History |
| 2020-06-24 5:26 pm Sale |
2020-06-22 | 13D | Precision BioSciences, Inc. DTIL |
venBio Global Strategic Fund L.P. | 102,115 5.900% |
-22,521 (-18.07%) |
Filing History |
| 2020-06-08 2:45 pm Sale |
2020-06-03 | 13D | Precision BioSciences, Inc. DTIL |
venBio Global Strategic Fund L.P. | 124,636 7.200% |
-17,535 (-12.33%) |
Filing History |